dc.contributor.author | Hattersley, Andrew T. | en |
dc.contributor.author | Thorens, B. | en |
dc.date.accessioned | 2016-08-09T14:36:03Z | |
dc.date.available | 2016-08-09T14:36:03Z | |
dc.date.issued | 2015-09-03 | |
dc.identifier.citation | Type 2 Diabetes, SGLT2 Inhibitors, and Glucose Secretion. 2015, 373 (10):974-6 N. Engl. J. Med. | en |
dc.identifier.issn | 1533-4406 | |
dc.identifier.pmid | 26332554 | |
dc.identifier.doi | 10.1056/NEJMcibr1506573 | |
dc.identifier.uri | http://hdl.handle.net/11287/618135 | |
dc.language.iso | en | en |
dc.publisher | NEJM | en |
dc.relation.url | http://www.nejm.org/doi/abs/10.1056/NEJMcibr1506573?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed | en |
dc.rights | Archived with thanks to The New England journal of medicine | en |
dc.subject | Wessex Classification Subject Headings::Endocrinology::Diabetes | en |
dc.subject | Wessex Classification Subject Headings::Oncology. Pathology.::Genetics | en |
dc.title | Type 2 Diabetes, SGLT2 Inhibitors, and Glucose Secretion. | en |
dc.type | Journal Article | en |
dc.identifier.journal | The New England Journal of Medicine | en |
dc.type.version | Published | en |